Infection of lung epithelial cells with pandemic 2009 a(H1N1) influenza viruses reveals isolate-specific differences in infectivity and host cellular responses

Viral Immunology

Volumn 24, Issue 2, 2011, Pages 89-99

  Patel, Jenish R ^a   Vora, Keyur P ^a   Tripathi, Shashank ^a   Zeng, Hui ^a   Tumpey, Terrence M ^a   Katz, Jacqueline M ^a   Sambhara, Suryaprakash ^a   Gangappa, Shivaprakash ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INFLUENZA VACCINE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

AMINO ACID SEQUENCE; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA VIRUS A H1N1; LUNG ALVEOLUS EPITHELIUM; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPRING; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS STRAIN;

CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; VIRULENCE;

ORTHOMYXOVIRIDAE;

EID: 79953238050     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0122     Document Type: Article

References (69)

1. Centers for Disease Control and Prevention: Intensive-care patients with severe novel influenza A (H1N1) virus infection\Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-752.
2. Centers for Disease Control and Prevention: Outbreak of swine-origin influenza A (H1N1) virus infection\Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:467-470.
3. Centers for Disease Control and Prevention: Update: novel influenza A (H1N1) virus infections\worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 2009;58: 453-458.
4. Centers for Disease Control and Prevention: Update: swine influenza A (H1N1) infections\California and Texas, April 2009. MMWR Morb Mortal Wkly Rep 2009;58:435-437.
5. Adachi M, Matsukura S, Tokunaga H, and Kokubu F: Expression of cytokines on human bronchial epithelial cells induced by influenza virus A. Int Arch Allergy Immunol 1997;113:307-311. (Pubitemid 27160796)
6. Arndt U, Wennemuth G, Barth P, et al.: Release of macro-phage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol 2002;76:9298-9306. (Pubitemid 34919888)
7. Belshe RB, Edwards KM, Vesikari T, et al.: Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356:685-696.
8. Bernasconi D, Amici C, La Frazia S, Ianaro A, and Santoro MG: The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine produc-tion in airway epithelial cells. J Biol Chem 2005;280:24127-24134. (Pubitemid 40884900)
9. Brydon EW, Smith H, and Sweet C: Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. J Gen Virol 2003; 84:2389-2400. (Pubitemid 37063128)
10. Carrat F, and Flahault A: Influenza vaccine: the challenge of antigenic drift. Vaccine 2007;25:6852-6862. (Pubitemid 47398929)
11. Cheung CY, Poon LL, Lau AS, et al.: Induction of proin-flammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002;360:1831-1837 (Pubitemid 35449422)
12. Choi AM, and Jacoby DB: Influenza virus A infection in-duces interleukin-8 gene expression in human airway epi-thelial cells. FEBS Lett 1992;309:327-329.
13. Choi YK, Kim TK, Kim CJ, et al.: Activation of the intrinsic mitochondrial apoptotic pathway in swine influenza virus-mediated cell death. Exp Mol Med 2006;38:11-17.
14. Dawood FS, Jain S, Finelli L, et al.: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
15. de Jong MD, Simmons CP, Thanh TT, et al.: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1237.
16. Ebisawa IT, Kitamoto O, Takeuchi Y, and Makino M: Immunocytologic study of nasal epithelial cells in influenza. Am Rev Respir Dis 1969;99:507-515.
17. Egorov A, Brandt S, Sereinig S, et al.: Transfectant influenza A viruses with long deletions in the NS1 protein grow effi-ciently in Vero cells. J Virol 1998;72: 6437-6441. (Pubitemid 28323956)
18. Falcon AM, Marion RM, Zurcher T, Gomez P, Portela A, Nieto A, and Ortin J: Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol 2004;78: 3880-3888. (Pubitemid 38437194)
19. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997;61:246-257. (Pubitemid 27149903)
20. Fernandez-Sesma A, Marukian S, Ebersole BJ, et al.: Influ-enza virus evades innate and adaptive immunity via the NS1 protein. J Virol 2006;80:6295-6304. (Pubitemid 43927432)
21. Fraser C, Donnelly CA, Cauchemez S, et al.: Pandemic po-tential of a strain of influenza A (H1N1): early findings. Science 2009;324:1557-1561.
22. Garcia-Sastre A, Egorov A, Matassov D, et al.: Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998;252:324-330. (Pubitemid 29013414)
23. Garten RJ, Davis CT, Russell CA, et al.: Antigenic and ge-netic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
24. Geiss GK, Salvatore M, Tumpey TM, et al.: Cellular tran-scriptional profiling in influenza A virus-infected lung epi-thelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contri-bution to pandemic influenza. Proc Natl Acad Sci USA 2002;99:10736-10741.
25. Gentile D, Doyle W, Whiteside T, Fireman P, Hayden FG, and Skoner D: Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin Diagn Lab Immunol 1998;5:604-608. (Pubitemid 29030752)
26. Hale BG, Randall RE, Ortin J, and Jackson D: The multi-functional NS1 protein of influenza A viruses. J Gen Virol 2008;89:2359-2376.
27. Hancock K, Veguilla V, Lu X, et al.: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-1952.
28. Hanslik T, Boelle PY, and Flahault A: Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza vi-rus, France, 2009-2010. PLoS Curr Influenza 2009;RRN1150.
29. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, and Straus SE: Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-649. (Pubitemid 28084248)
30. Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, Goodbourn S, and Barclay W: Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 2006;347:52-64.
31. Herold S, von Wulffen W, Steinmueller M, et al.: Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 2006;177:1817-1824. (Pubitemid 44092519)
32. Jain S, Kamimoto L, Bramley AM, et al.: Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-1944.
33. Jaspers I, Ciencewicki JM, Zhang W, Brighton LE, Carson JL, Beck MA, and Madden MC: Diesel exhaust enhances influ-enza virus infections in respiratory epithelial cells. Toxicol Sci 2005;85:990-1002. (Pubitemid 40846874)
34. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, and Matikainen S: Inflammatory responses in influenza A virus infection. Vaccine 2000;19(Suppl 1):S32-S37. (Pubitemid 32121717)
35. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, and Matikainen S: Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene Expression. Cytokine Growth Factor Rev 2001;12:171-180. (Pubitemid 32588143)
36. Kaiser L, Fritz RS, Straus SE, Gubareva L, and Hayden FG Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 2001;64:262-268. (Pubitemid 32565121)
37. Kawaguchi M, Kokubu F, Kuga H, Tomita T, Matsukura S, Kadokura M, and Adachi M: Expression of eotaxin by normal airway epithelial cells after influenza virus A infection. Int Arch Allergy Immunol 2000;122(Suppl 1):44-49. (Pubitemid 30326335)
38. Kawaoka Y, Krauss S, and Webster RG: Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989;63:4603-4608. (Pubitemid 19257834)
39. Levi R, Beeor-Tzahar T, and Arnon R Microculture virus titration\a simple colourimetric assay for influenza virus titration. J Virol Methods 1995;52:55-64.
40. Lowy RJ: Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms. Int Rev Immunol2003;22:425-449. (Pubitemid 37247661)
41. Ludwig S, and Planz O: Influenza viruses and the NF-kappaB signaling pathway\towards a novel concept of antiviral therapy. Biol Chem 2008;389:1307-1312.
42. Matsukura S, Kokubu F, Kubo H, et al.: Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol 1998;18:255-264. (Pubitemid 128355199)
43. Matsukura S, Kokubu F, Noda H, Tokunaga H, and Adachi M: Expression of IL-6, IL-8, and RANTES on human bron-chial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 1996;98:1080-1087. (Pubitemid 27014801)
44. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, et al: Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010;65:645-651.
45. Osterlund P, Pirhonen J, Ikonen N, et al.: Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sen-sitive to the antiviral actions of interferons. J Virol 2009;84: 1414-1422.
46. Pebody RG, McLean E, Zhao H, et al.: Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 2010;15.
47. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, and Tumpey TM: H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macro-phages and neutrophils in the lungs of mice. PLoS Pathog 2008;4:e1000115.
48. Qian XY, Chien CY, Lu Y, Montelione GT, and Krug RM: An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1995;1:948-956.
49. Reed KD, Meece JK, Henkel JS, and Shukla SK: Birds, mi-gration and emerging zoonoses: West Nile virus, Lyme dis-ease, influenza A and enteropathogens. Clin Med Res 2003; 1:5-12.
50. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, Keskinen P, and Julkunen I: Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene Expression in influenza A-infected human lung epithelial cells. J Immunol 1997;158:2363-2374. (Pubitemid 127470023)
51. Shinde V, Bridges CB, Uyeki TM, et al.: Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009;360:2616-2625.
52. Sidwell RW, and Smee DF: In vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Res 2000; 48:1-16.
53. Skoner DP, Gentile DA, Patel A, and Doyle WJ: Evidence for cytokine mediation of disease expression in adults experi-mentally infected with influenza A virus. J Infect Dis 1999; 180:10-14. (Pubitemid 29293911)
54. Sladkova T, and Kostolansky F: The role of cytokines in the immune response to influenza A virus infection. Acta Virol 2006;50:151-162. (Pubitemid 46030056)
55. Sprenger H, Meyer RG, Kaufmann A, Bussfeld D, Risch-kowsky E, and Gemsa D: Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med 1996;184:1191-1196.
56. Svitek N, Rudd PA, Obojes K, Pillet S, and von Messling V: Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 2008;376: 53-59.
57. Taub DD, Lloyd AR, Conlon K, et al.: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993;177:1809-1814. (Pubitemid 23146150)
58. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, and Fukuda K: Mortality associated with in-fluenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186. (Pubitemid 36068705)
59. Vaillant L, La Ruche G, Tarantola A, and Barboza P: Epi-demiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009;14.
60. Van Reeth K: Cytokines in the pathogenesis of influenza. Vet Microbiol 2000;74:109-116. (Pubitemid 30224649)
61. Vester D, Rapp E, Gade D, Genzel Y, and Reichl U: Quan-titative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics 2009;9:3316-3327.
62. Walls HH, Harmon MW, Slagle JJ, Stocksdale C, and Kendal AP: Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses. J Clin Microbiol 1986;23:240-245. (Pubitemid 16155281)
63. Wang G, Zhang J, Li W, et al.: Apoptosis and proin-flammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses. Cell Mol Immunol 2008;5:113-120.
64. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, and Krug RM: RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 1999;5: 195-205. (Pubitemid 29079280)
65. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, and Garcia-Sastre A: Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 2000;74:11566-11573. (Pubitemid 32222305)
66. Webster RG: Influenza virus: transmission between species and relevance to emergence of the next human pandemic Arch Virol Suppl 1997;13:105-113. (Pubitemid 127502136)
67. Wolstenholme AJ, Barrett T, Nichol ST, and Mahy BW: Influenza virus-specific RNA and protein syntheses in cells infected with temperature-sensitive mutants defective in the genome segment encoding nonstructural proteins. J Virol 1980;35:1-7 (Pubitemid 10080336)
68. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, and Yuen KY: Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strate-gies. J Infect Dis 2010;201:346-353.
69. Zeng H, Goldsmith C, Thawatsupha P, et al.: Highly path-ogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J Virol 2007;81:12439-12449. (Pubitemid 350085857)